Abstract: Provided are methods of producing an electrode capable of binding an analyte thereto comprising: providing a substrate capable of binding a dithiol molecule thereto; electrochemically treating the substrate using cyclic voltammetry to provide a treated substrate having a fractal dimension of greater than about 2; and contacting the treated substrate with dithiol molecules to produce an electrode having dithiol groups attached thereto and capable of binding an analyte to be detected thereto. Also provided are methods of accumulating and detecting analytes using the electrodes produced via the methods of the present invention.

Abstract: Provided are methods of producing an electrode capable of binding an analyte thereto comprising: providing a substrate capable of binding a dithiol molecule thereto; electrochemically treating the substrate using cyclic voltammetry to provide a treated substrate having a fractal dimension of greater than about 2; and contacting the treated substrate with dithiol molecules to produce an electrode having dithiol groups attached thereto and capable of binding an analyte to be detected thereto. Also provided are methods of accumulating and detecting analytes using the electrodes produced via the methods of the present invention.

Abstract: The present invention concerns a sensor array and related testing apparatus for rapidly detecting the presence and/or concentration of constituents in samples, particularly biological molecules in fluid samples, including associated testing methods. The invention can be adapted such that a plurality of the sensors each detect a different constituent so that the invention can rapidly detect multiple constituents in a single sample. The sensors may be arranged in an array and connected by a plurality of micro channels that are fed from a main channel into which the sample is introduced. Positive pressure can be applied to the main and micro channels by a micro-pump. Alternately, it can be adapted to detect one or more constituents in a plurality of separate samples. A plurality of sensors are provided, each comprising electrochemical cells comprising an anode, a cathode and a reference electrode separated from each other by one or more filters within which an electrolyte is suspended.

Abstract: Methods are described for detecting and quantifying occult blood in a biological sample using laser desorption mass spectrometry (LD MS). Biological samples that can be analyzed using various embodiments of the present invention include stool (fecal occult blood, FOB), and any bodily fluid including urine, cerebrospinal fluid and other bodily fluids. If the heme or heme metabolite is bound to protein, the sample is treated with acid before analysis to release the porphyrin. Some of the methods use LD MS with a time of flight analyzer (TOF) to detect and measure unbound heme, other hemoglobin metabolites and other molecules that have a porphyrin-based structure, e.g., bilirubin, biliverdin, protoporphyrin IX, and Zinc protoporphyrin in the biological sample. In other methods, matrix-assisted laser desorption/ionization mass spectrometry (MALDI MS) is used to detect and quantify the individual &agr;- and &bgr;-polypeptide chains of hemoglobin.

Abstract: This invention involves method and apparatus for guiding ablative therapy of abnormal biological electrical excitation. In particular, it is designed for treatment of cardiac arrhythmias. In the method of this invention electrical signals are acquired from passive electrodes, and an inverse dipole method is used to identify the site of origin of an arrhythmia. The location of the tip of the ablation catheter is similarly localized from signals acquired from the passive electrodes while electrical energy is delivered to the tip of the catheter. The catheter tip is then guided to the site of origin of the arrhythmia, and ablative radio frequency energy is delivered to its tip to ablate the site.

Abstract: This invention involves method and apparatus for guiding ablative therapy of abnormal biological electrical excitation. In particular, it is designed for treatment of cardiac arrhythmias. In the method of this invention electrical signals are acquired from passive electrodes, and an inverse dipole method is used to identify the site of origin of an arrhytmia. The location of the tip of the ablation catheter is similarly localized from signals acquired from the passive electrodes while electrical energy is delivered to the tip of the catheter. The catheter tip is then guided to the site of origin of the arrhythmia, and ablative radio frequency energy is delivered to its tip to ablate the site.